N. H. Tran

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

P. Pitisuttithum, K. Rusmil, D. Vliet, 2014, The Lancet.

Three Decades of Dengue Surveillance in Five Highly Endemic South East Asian Countries

M. R. Capeding, N. H. Tran, S. Hadinegoro, 2017, Asia-Pacific journal of public health.

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials

L. Shek, N. H. Tran, Chan Quang Luong, 2019, Human vaccines & immunotherapeutics.

Safety and Immunogenicity of Recombinant, Live Attenuated Tetravalent Dengue Vaccine (CYD- TDV) in Healthy Vietnamese Adults and Children

J. Lang, N. H. Tran, Chan Quang Luong, 2012 .

Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America.

N. H. Tran, S. Hadinegoro, T. Chotpitayasunondh, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials

P. Pitisuttithum, N. H. Tran, A. Bouckenooghe, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial

Joshua Nealon, Sri Rezeki Hadinegoro, M. R. Capeding, 2016, PLoS neglected tropical diseases.